• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Biosimilars

The AJMC® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory updates.

Latest News

FDA approval stamp in red | Image credit: chrisdorney - stock.adobe.com
FDA Approves First 2 Denosumab Biosimilars

March 5th 2024

Wyost and Jubbonti were approved as interchangeable biosimilars for Xgeva and Prolia; however, there is no launch date yet pending litigation with the maker of the reference products.

Doctor stacking wooden blocks with health care icons | image credit: REDPIXEL - stock.adobe.com
Navigating the Biosimilar Frontier: Opportunities and Challenges in 2024

January 14th 2024

stethoscope and gavel | Image credit: Andrey Popov - stock.adobe.com
CareFirst Files Lawsuit Against J&J Over Delay Tactics for Stelara Biosimilars

January 1st 2024

Highlights from Asembia Speciality Pharmacy Summit 2023
Top 5 Content From Asembia 2023

December 31st 2023

The Top 5 SAP Content of 2023
Top 5 Strategic Alliance Partnership Content of 2023

December 29th 2023

More News

© 2024 MJH Life Sciences
AJMC®
All rights reserved.